Processes of care in the multidisciplinary treatment of gastric cancer: Results of a RAND/UCLA expert panel

JAMA Surgery

Volumn 149, Issue 1, 2014, Pages 18-25

  Brar, Savtaj S ^a   Mahar, Alyson L ^b,c   Helyer, Lucy K ^d   Swallow, Carol ^a   Law, Calvin ^a   Paszat, Lawrence ^e   Seevaratnam, Rajini ^c   Cardoso, Roberta ^c   McLeod, Robin ^a   Dixon, Matthew ^f   Yohanathan, Lavanya ^g   Lourenco, Laercio G ^h   Bocicariu, Alina ^c   Bekaii Saab, Tanios ⁱ   Chau, Ian ^j   Church, Neal ^k   Coit, Daniel ^l   Crane, Christopher H ^m   Earle, Craig ^a,e   Mansfield, Paul ^m   Marcon, Norman ^a   Miner, Thomas ^g   Noh, Sung Hoon ⁿ   Porter, Geoff ^d   Posner, Mitchell C ^o   Prachand, Vivek ^o   Sano, Takeshi ^p   Van De Velde, Cornelis ^q   Wong, Sandra ^r   Coburn, Natalie G ^a,c,e   more..

^a UNIVERSITY OF TORONTO   (Canada)

^b QUEEN S UNIVERSITY   (Canada)

^c DEPARTMENT OF RADIATION ONCOLOGY   (Canada)

^d DALHOUSIE UNIVERSITY   (Canada)

^e Institute for Clinical Evaluation Sciences   (Canada)

^f MAIMONIDES MEDICAL CENTER   (United States)

^g BROWN UNIVERSITY   (United States)

^h FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

ⁱ OHIO STATE UNIVERSITY   (United States)

^j ROYAL MARSDEN HOSPITAL   (United Kingdom)

^k UNIVERSITY OF CALGARY   (Canada)

^l MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^m UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

ⁿ Yonsei University College of Medicine   (South Korea)

^o UNIVERSITY OF CHICAGO   (United States)

^p CANCER INSTITUTE HOSPITAL   (Japan)

^q LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^r UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADJUVANT CHEMORADIOTHERAPY; ARTICLE; CANCER CHEMOTHERAPY; CANCER STAGING; CARCINOMATOUS PERITONITIS; ENDOSCOPIC MUCOSAL RESECTION; ENDOSCOPIC SURGERY; ENDOSCOPY; GASTRECTOMY; HEALTH CARE QUALITY; HUMAN; INTRAOPERATIVE PERIOD; LIVER METASTASIS; METASTASIS; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; STOMACH ADENOCARCINOMA; ADENOCARCINOMA; CLINICAL TRIAL; MULTICENTER STUDY; MULTIMODALITY CANCER THERAPY; PATIENT CARE; STOMACH NEOPLASMS;

ADENOCARCINOMA; COMBINED MODALITY THERAPY; HUMANS; PATIENT CARE TEAM; STOMACH NEOPLASMS;

EID: 84892681723     PISSN: 21686254     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamasurg.2013.3959     Document Type: Article

References (36)

1. Jemal A, Bray F, Center MM, Ferlay J,Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61(2):69-90.
2. Cunningham D, Allum WH, Stenning SP, et al. MAGIC Trial Participants. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med. 2006;355(1):11-20.
3. Macdonald JS, Smalley SR, Benedetti J, et al. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med. 2001;345(10):725-730.
4. Paoletti X, Oba K, Burzykowski T, et al. GASTRIC (Global Advanced/Adjuvant Stomach Tumor Research International Collaboration) Group. Benefit of adjuvant chemotherapy for resectable gastric cancer: ameta-analysis. JAMA. 2010;303(17):1729-1737.
5. Sakuramoto S, SasakoM, Yamaguchi T, et al. ACTS-GC Group. Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. N Engl J Med. 2007;357(18):1810-1820.
6. Coburn NG, Lourenco LG, Rossi SE, et al. Management of gastric cancer in Ontario. J Surg Oncol. 2010;102(1):54-63.
7. Sherman KL, Merkow RP, Bilimoria KY, et al. Treatment trends and predictors of adjuvant and neoadjuvant therapy for gastric adenocarcinoma in the United States. Ann Surg Oncol. 2013;20(2):362-370.
8. Mahar AL, Coburn NG, Singh S, Law C, Helyer LK. A systematic review of surgery for non-curative gastric cancer. Gastric Cancer. 2012;15(SUPPL. 1):S125-S137.
9. Fitch K. The RAND/UCLA Appropriateness Method User's Manual. Santa Monica, CA: RAND Corp; 2001.
10. Brar SS, Seevaratnam R, Cardoso R, Law C, Helyer L, Coburn N. A systematic review of spleen and pancreas preservation in extended lymphadenectomy for gastric cancer. Gastric Cancer. 2012;15(SUPPL. 1):S89-S99.
11. Cardoso R, Bocicariu A, DixonM, et al. What is the accuracy of sentinel lymph node biopsy for gastric cancer? a systematic review. Gastric Cancer. 2012;15(SUPPL. 1):S48-S59.
12. Cardoso R, Coburn N, Seevaratnam R, et al. A systematic review and meta-analysis of the utility of EUS for preoperative staging for gastric cancer. Gastric Cancer. 2012;15(SUPPL. 1):S19-S26.
13. Cardoso R, Coburn NG, Seevaratnam R, et al. A systematic review of patient surveillance after curative gastrectomy for gastric cancer: a brief review. Gastric Cancer. 2012;15(SUPPL. 1):S164-S167.
14. Leake PA, Cardoso R, Seevaratnam R, et al. A systematic review of the accuracy and indications for diagnostic laparoscopy prior to curative-intent resection of gastric cancer. Gastric Cancer. 2012;15(SUPPL. 1):S38-S47.
15. Leake PA, Cardoso R, Seevaratnam R, et al. A systematic review of the accuracy and utility of peritoneal cytology in patients with gastric cancer. Gastric Cancer. 2012;15(SUPPL. 1):S27-S37.
16. Mahar AL, Coburn NG, Karanicolas PJ, Viola R, Helyer LK. Effective palliation and quality of life outcomes in studies of surgery for advanced, non-curative gastric cancer: a systematic review. Gastric Cancer. 2012;15(SUPPL. 1):S138-S145.
17. Mahar AL, McLeod RS, Kiss A, et al. A systematic review of the effect of institution and surgeon factors on surgical outcomes for gastric cancer. J AmColl Surg. 2012;214(5):860-868.
18. Raziee HR, Cardoso R, Seevaratnam R, et al. Systematic review of the predictors of positive margins in gastric cancer surgery and the effect on survival. Gastric Cancer. 2012;15(SUPPL. 1):S116-S124.
19. Roberts P, Seevaratnam R, Cardoso R, Law C, Helyer L, Coburn N. Systematic review of pancreaticoduodenectomy for locally advanced gastric cancer. Gastric Cancer. 2012;15 (SUPPL. 1):S108-S115.
20. Seevaratnam R, Bocicariu A, Cardoso R, et al. How many lymph nodes should be assessed in patients with gastric cancer? a systematic review. Gastric Cancer. 2012;15(SUPPL. 1):S70-S88.
21. Brook RH, Chassin MR, Fink A, Solomon DH, Kosecoff J, Park RE. Amethod for the detailed assessment of the appropriateness of medical technologies. Int J Technol Assess Health Care. 1986;2(1):53-63.
22. Bilimoria KY, Bentrem DJ, Lillemoe KD, TalamontiMS, Ko CY; Pancreatic Cancer Quality Indicator Development Expert Panel, American College of Surgeons. Assessment of pancreatic cancer care in the United States based on formally developed quality indicators. J Natl Cancer Inst. 2009;101(12):848-859.
23. Bilimoria KY, Raval MV, Bentrem DJ,Wayne JD, Balch CM, Ko CY. National assessment of melanoma care using formally developed quality indicators. J Clin Oncol. 2009;27(32):5445-5451.
24. McGoryML, Shekelle PG, Ko CY. Development of quality indicators for patients undergoing colorectal cancer surgery. J Natl Cancer Inst. 2006;98(22):1623-1633.
25. Knight G, Earle CC, Cosby R, et al. Gastrointestinal Cancer Disease Site Group. Neoadjuvant or adjuvant therapy for resectable gastric cancer: a systematic review and practice guideline for North America. Gastric Cancer. 2013;16(1):28-40.
26. Davies AR, Deans DA, Penman I, et al. The multidisciplinary team meeting improves staging accuracy and treatment selection for gastro-esophageal cancer. Dis Esophagus. 2006;19(6):496-503.
27. Ajani JA, Barthel JS, Bekaii-Saab T, et al. NCCN Gastric Cancer Panel. Gastric cancer. J Natl Compr Canc Netw. 2010;8(4):378-409.
28. Allum WH, Blazeby JM, Griffin SM, Cunningham D, Jankowski JA,Wong R; Association of Upper Gastrointestinal Surgeons of Great Britain and Ireland, the British Society of Gastroenterology and the British Association of Surgical Oncology. Guidelines for the management of oesophageal and gastric cancer. Gut. 2011;60(11):1449-1472.
29. Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2010 (ver. 3). Gastric Cancer. 2011;14(2):113-123.
30. Okines A, VerheijM, AllumW, Cunningham D, Cervantes A; ESMO GuidelinesWorking Group. Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2010;21(SUPPL. 5):v50-v54.
31. Van CutsemE, DicatoM, Geva R, et al. The diagnosis and management of gastric cancer: expert discussion and recommendations from the 12th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2010. Ann Oncol. 2011;22 (SUPPL. 5):v1-v9.
32. Wagner AD, Unverzagt S, GrotheW, et al. Chemotherapy for advanced gastric cancer. Cochrane Database Syst Rev. 2010;(3):CD004064. doi: 10.1002/14651858.CD004064.pub3.
33. Fujitani K, Yang HK, Kurokawa Y, et al. Gastric Cancer Surgical Study Group of Japan Clinical Oncology Group; Korea Gastric Cancer Association. Randomized controlled trial comparing gastrectomy plus chemotherapy with chemotherapy alone in advanced gastric cancer with a single non-curable factor: Japan Clinical Oncology Group Study JCOG 0705 and Korea Gastric Cancer Association Study KGCA01. Jpn J Clin Oncol. 2008;38(7):504-506.
34. Kerkar SP, Kemp CD, Duffy A, et al. The GYMSSA trial: a prospective randomized trial comparing gastrectomy, metastasectomy plus systemic therapy versus systemic therapy alone. Trials. 2009;10:121. doi: 10.1186/1745-6215-10- 121.
35. Yan TD, Black D, Sugarbaker PH, et al. A systematic review and meta-analysis of the randomized controlled trials on adjuvant intraperitoneal chemotherapy for resectable gastric cancer. Ann Surg Oncol. 2007;14(10):2702- 2713.
36. Yang XJ, Huang CQ, Suo T, et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy improves survival of patients with peritoneal carcinomatosis from gastric cancer: final results of a phase III randomized clinical trial. Ann Surg Oncol. 2011;18(6):1575-1581.